Compare Stocks: AAPG, IMVT, KOD, and CGON

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AAPG Ascentage Pharma Group International	$15.37 +4.6%	$16.48	$14.45 ▼ $35.86	$1.44B	0.12	7,063 shs	15,091 shs
CGON CG Oncology	$59.85 -3.2%	$72.27	$35.80 ▼ $80.97	$5.31B	0.28	1.12 million shs	1.08 million shs
IMVT Immunovant	$26.73 -2.8%	$37.28	$17.02 ▼ $45.42	$5.52B	0.84	1.72 million shs	1.46 million shs
KOD Kodiak Sciences	$85.75 -2.7%	$53.41	$13.95 ▼ $104.00	$5.39B	2.03	3.99 million shs	1.12 million shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AAPG Ascentage Pharma Group International	0.00%	+5.06%	+1.47%	-17.98%	-58.34%
CGON CG Oncology	0.00%	-6.22%	-20.85%	-16.70%	+39.02%
IMVT Immunovant	0.00%	-12.27%	-29.00%	-33.61%	+49.08%
KOD Kodiak Sciences	0.00%	-14.14%	+161.04%	+101.10%	+476.28%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AAPG Ascentage Pharma Group International	$15.37 +4.6%	$16.48	$14.45 ▼ $35.86	$1.44B	0.12	7,063 shs	15,091 shs
CGON CG Oncology	$59.85 -3.2%	$72.27	$35.80 ▼ $80.97	$5.31B	0.28	1.12 million shs	1.08 million shs
IMVT Immunovant	$26.73 -2.8%	$37.28	$17.02 ▼ $45.42	$5.52B	0.84	1.72 million shs	1.46 million shs
KOD Kodiak Sciences	$85.75 -2.7%	$53.41	$13.95 ▼ $104.00	$5.39B	2.03	3.99 million shs	1.12 million shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AAPG Ascentage Pharma Group International	0.00%	+5.06%	+1.47%	-17.98%	-58.34%
CGON CG Oncology	0.00%	-6.22%	-20.85%	-16.70%	+39.02%
IMVT Immunovant	0.00%	-12.27%	-29.00%	-33.61%	+49.08%
KOD Kodiak Sciences	0.00%	-14.14%	+161.04%	+101.10%	+476.28%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AAPG Ascentage Pharma Group International	3.14	Buy	$43.90	185.62% Upside
CGON CG Oncology	2.70	Moderate Buy	$87.50	46.20% Upside
IMVT Immunovant	2.58	Moderate Buy	$44.00	64.61% Upside
KOD Kodiak Sciences	2.63	Moderate Buy	$104.71	22.12% Upside

Current Analyst Ratings Breakdown

Latest AAPG, IMVT, KOD, and CGON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/16/2026	AAPG Ascentage Pharma Group International	William Blair Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Outperform
10/15/2026	CGON CG Oncology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/14/2026	AAPG Ascentage Pharma Group International	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$46.00
10/13/2026	AAPG Ascentage Pharma Group International	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Outperform ➝ Buy	$46.00
10/13/2026	AAPG Ascentage Pharma Group International	Citizens Jmp Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Market Outperform	$35.00
10/12/2026	KOD Kodiak Sciences	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$96.00 ➝ $126.00
10/8/2026	AAPG Ascentage Pharma Group International	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Overweight	$46.00 ➝ $33.00
10/6/2026	KOD Kodiak Sciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
10/2/2026	IMVT Immunovant	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/30/2026	KOD Kodiak Sciences	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral	$103.00
9/28/2026	KOD Kodiak Sciences	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$112.00

(Data available from 10/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AAPG Ascentage Pharma Group International	$82.10M	17.49	N/A	N/A	$2.04 per share	7.53
CGON CG Oncology	$6.23M	851.82	N/A	N/A	$9.33 per share	6.41
IMVT Immunovant	N/A	N/A	N/A	N/A	$4.19 per share	N/A
KOD Kodiak Sciences	N/A	N/A	N/A	N/A	$2.97 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AAPG Ascentage Pharma Group International	-$177.71M	N/A	N/A	768.50	N/A	N/A	N/A	N/A	N/A
CGON CG Oncology	-$160.99M	-$2.69	N/A	N/A	N/A	-3,602.68%	-25.20%	-23.98%	11/13/2026 (Estimated)
IMVT Immunovant	-$505.61M	-$2.82	N/A	N/A	N/A	N/A	-69.59%	-62.49%	11/9/2026 (Estimated)
KOD Kodiak Sciences	-$229.97M	-$4.19	N/A	N/A	N/A	N/A	-273.23%	-85.48%	11/12/2026 (Estimated)

Latest AAPG, IMVT, KOD, and CGON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/13/2026	Q3 2026	CGON CG Oncology	-$0.8341	N/A	N/A	N/A	$0.55 million	N/A
11/12/2026	Q3 2026	KOD Kodiak Sciences	-$1.06	N/A	N/A	N/A	N/A	N/A
11/9/2026	Q2 2027	IMVT Immunovant	-$0.73	N/A	N/A	N/A	$7.10 million	N/A
8/19/2026	H1 2026	AAPG Ascentage Pharma Group International	N/A	-$0.65	N/A	-$0.6450	N/A	$22.24 million
8/13/2026	Q2 2026	KOD Kodiak Sciences	-$0.9565	-$1.05	-$0.0935	-$1.05	N/A	N/A
8/6/2026	Q2 2026	CGON CG Oncology	-$0.6642	-$0.90	-$0.2359	-$0.90	$0.36 million	$1.16 million
8/6/2026	Q1 2027	IMVT Immunovant	-$0.6289	-$0.75	-$0.1211	-$0.75	$7.10 million	$7.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AAPG Ascentage Pharma Group International	N/A	N/A	N/A	N/A	N/A
CGON CG Oncology	N/A	N/A	N/A	N/A	N/A
IMVT Immunovant	N/A	N/A	N/A	N/A	N/A
KOD Kodiak Sciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AAPG Ascentage Pharma Group International	1.09	1.22	1.18
CGON CG Oncology	N/A	22.22	22.20
IMVT Immunovant	N/A	7.27	7.27
KOD Kodiak Sciences	N/A	2.49	2.49

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AAPG Ascentage Pharma Group International	N/A
CGON CG Oncology	26.56%
IMVT Immunovant	47.08%
KOD Kodiak Sciences	89.06%

Insider Ownership

Company	Insider Ownership
AAPG Ascentage Pharma Group International	N/A
CGON CG Oncology	4.80%
IMVT Immunovant	1.90%
KOD Kodiak Sciences	44.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AAPG Ascentage Pharma Group International	767	93.40 million	N/A	N/A
CGON CG Oncology	142	88.64 million	84.39 million	Optionable
IMVT Immunovant	315	206.55 million	202.63 million	Optionable
KOD Kodiak Sciences	124	62.85 million	34.94 million	Optionable

AAPG, IMVT, KOD, and CGON Headlines

Recent News About These Companies

Kodiak Sciences Inc. (KOD) - What Are Investment Firms Saying About This Stock?

October 18 at 3:58 AM | americanbankingnews.com

HC Wainwright Expects Increased Earnings for Kodiak Sciences

October 16 at 1:59 AM | americanbankingnews.com

HC Wainwright Comments on Kodiak Sciences FY2030 Earnings

October 15 at 2:44 AM | americanbankingnews.com

FY2028 EPS Estimate for Kodiak Sciences Boosted by Analyst

October 14, 2026 | marketbeat.com

Kodiak Sciences (NASDAQ:KOD) Stock Price Down 7.7% - What's Next?

October 13, 2026 | marketbeat.com

Analysts Have Conflicting Sentiments on These Healthcare Companies: Kodiak Sciences (KOD), Newron Pharmaceuticals SpA (OtherNWPHF) and Illumina (ILMN)

October 13, 2026 | theglobeandmail.com

HC Wainwright Expects Higher Earnings for Kodiak Sciences

October 13, 2026 | marketbeat.com

Kodiak Sciences Inc. (KOD) - What Are Researchers Thinking About This Stock?

October 13, 2026 | marketbeat.com

HC Wainwright Issues Positive Forecast for Kodiak Sciences (NASDAQ:KOD) Stock Price

October 12, 2026 | marketbeat.com

Kodiak Sciences Inc. (KOD) Presents at American Academy of Ophthalmology Conference 2026 - Slideshow

October 10, 2026 | seekingalpha.com

Kodiak Sciences (KOD) Stock Trades At A Premium On DAYBREAK Trial News

October 9, 2026 | finance.yahoo.com

Kodiak Sciences (KOD) Could Be 7% Overvalued Following Late Stage Data Update

October 8, 2026 | finance.yahoo.com

Kodiak Sciences stock heads into AAO data on October 9

October 8, 2026 | ad-hoc-news.deA

Wall Street Zen upgrades Kodiak Sciences stock to Sell

October 8, 2026 | ad-hoc-news.deA

Kodiak Sciences Inc. Presents Clinical Data Across All Three Late-Stage Programs At AAO 2026

October 7, 2026 | marketscreener.comM

Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026

October 7, 2026 | prnewswire.com

Kodiak Sciences stock gets closer to a BLA after DAYBREAK data

October 5, 2026 | ad-hoc-news.deA

Kodiak Sciences stock fell 4.07 percent on October 2 after DAYBREAK data

October 4, 2026 | ad-hoc-news.deA

Kodiak Sciences (NASDAQ:KOD) Stock Bumped Up to Sell by Wall Street Zen

October 4, 2026 | marketbeat.com

Kodiak Sciences consensus price target increased by 65.16% to $117.50

October 2, 2026 | msn.com

This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking

October 2, 2026 | biopharmadive.comB

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AAPG, IMVT, KOD, and CGON Company Descriptions

Ascentage Pharma Group International NASDAQ:AAPG

$15.37 +0.68 (+4.63%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$15.38 +0.01 (+0.03%)

As of 10/16/2026 07:30 PM Eastern

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.

CG Oncology NASDAQ:CGON

$59.85 -2.01 (-3.25%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$59.83 -0.02 (-0.03%)

As of 10/16/2026 07:31 PM Eastern

CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008 for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. The company was founded in 2010 and is based in Irvine, California.

Immunovant NASDAQ:IMVT

$26.73 -0.78 (-2.84%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$26.41 -0.32 (-1.20%)

As of 10/16/2026 07:32 PM Eastern

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Kodiak Sciences NASDAQ:KOD

$85.75 -2.37 (-2.69%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$87.00 +1.25 (+1.46%)

As of 10/16/2026 07:30 PM Eastern

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AAPG, IMVT, KOD, and CGON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AAPG, IMVT, KOD, and CGON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AAPG, IMVT, KOD, and CGON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AAPG, IMVT, KOD, and CGON Company Descriptions

Ascentage Pharma Group International NASDAQ:AAPG

CG Oncology NASDAQ:CGON

Immunovant NASDAQ:IMVT

Kodiak Sciences NASDAQ:KOD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AAPG, IMVT, KOD, and CGON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AAPG, IMVT, KOD, and CGON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AAPG, IMVT, KOD, and CGON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AAPG, IMVT, KOD, and CGON Company Descriptions

Ascentage Pharma Group International NASDAQ:AAPG

CG Oncology NASDAQ:CGON

Immunovant NASDAQ:IMVT

Kodiak Sciences NASDAQ:KOD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools